Thomas R. Hird

31.4k total citations
18 papers, 473 citations indexed

About

Thomas R. Hird is a scholar working on Epidemiology, General Health Professions and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Thomas R. Hird has authored 18 papers receiving a total of 473 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Epidemiology, 5 papers in General Health Professions and 5 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Thomas R. Hird's work include Chronic Disease Management Strategies (4 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (4 papers) and Global Public Health Policies and Epidemiology (4 papers). Thomas R. Hird is often cited by papers focused on Chronic Disease Management Strategies (4 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (4 papers) and Global Public Health Policies and Epidemiology (4 papers). Thomas R. Hird collaborates with scholars based in United Kingdom, Australia and South Africa. Thomas R. Hird's co-authors include Nicholas C. Grassly, Dianna J. Magliano, Danny Liew, Ella Zomer, Alice Owen, Zanfina Ademi, Tonya M. Esterhuizen, Ayesha A. Motala, Mark I. McCarthy and Lei Chen and has published in prestigious journals such as PLoS ONE, Diabetes and Scientific Reports.

In The Last Decade

Thomas R. Hird

17 papers receiving 466 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thomas R. Hird United Kingdom 10 188 150 101 83 74 18 473
Qaiser Mukhtar United States 10 131 0.7× 61 0.4× 92 0.9× 84 1.0× 172 2.3× 22 463
Souha Bougatef Tunisia 13 75 0.4× 40 0.3× 143 1.4× 139 1.7× 49 0.7× 28 509
Esegiel Gaeb Namibia 8 185 1.0× 76 0.5× 61 0.6× 97 1.2× 63 0.9× 10 453
Fernando Wyss Guatemala 11 245 1.3× 66 0.4× 25 0.2× 82 1.0× 40 0.5× 49 495
S Shekhawat India 14 125 0.7× 119 0.8× 94 0.9× 120 1.4× 29 0.4× 23 566
Mary Mayige Tanzania 12 32 0.2× 77 0.5× 135 1.3× 59 0.7× 28 0.4× 25 364
Modou Jobe Gambia 11 77 0.4× 59 0.4× 40 0.4× 70 0.8× 25 0.3× 40 330
Michael Asamoah-Boaheng Canada 11 33 0.2× 141 0.9× 69 0.7× 70 0.8× 47 0.6× 43 426
James Osei-Yeboah Ghana 13 50 0.3× 92 0.6× 172 1.7× 163 2.0× 49 0.7× 41 501
Suok‐Kai Chew Singapore 12 91 0.5× 118 0.8× 163 1.6× 187 2.3× 19 0.3× 18 431

Countries citing papers authored by Thomas R. Hird

Since Specialization
Citations

This map shows the geographic impact of Thomas R. Hird's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas R. Hird with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas R. Hird more than expected).

Fields of papers citing papers by Thomas R. Hird

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas R. Hird. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas R. Hird. The network helps show where Thomas R. Hird may publish in the future.

Co-authorship network of co-authors of Thomas R. Hird

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas R. Hird. A scholar is included among the top collaborators of Thomas R. Hird based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas R. Hird. Thomas R. Hird is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Matthes, Britta, et al.. (2023). Advocacy counterstrategies to tobacco industry interference in policymaking: a scoping review of peer-reviewed literature. Globalization and Health. 19(1). 42–42. 5 indexed citations
2.
Hird, Thomas R., et al.. (2022). Tobacco industry messaging around harm: Narrative framing in PMI and BAT press releases and annual reports 2011 to 2021. Frontiers in Public Health. 10. 958354–958354. 8 indexed citations
3.
Hird, Thomas R., Karen Evans-Reeves, Mateusz Zatoński, et al.. (2022). Understanding the long-term policy influence strategies of the tobacco industry: two contemporary case studies. Tobacco Control. 31(2). 297–307. 20 indexed citations
4.
Hird, Thomas R., Pravi Moodley, Fraser Pirie, et al.. (2021). HIV infection and anaemia do not affect HbA1c for the detection of diabetes in black South Africans: Evidence from the Durban Diabetes Study. Diabetic Medicine. 38(11). e14605–e14605. 3 indexed citations
5.
Hird, Thomas R., Phil Chamberlain, & Anna Gilmore. (2021). Tobacco industry tactics to undermine tobacco control.. 136–149.
6.
Zatoński, Mateusz, Anna Gilmore, & Thomas R. Hird. (2020). The two faces of the tobacco industry during the COVID-19 pandemic. Tobacco Control. 5 indexed citations
7.
Chen, Lei, Rakibul M. Islam, Thomas R. Hird, et al.. (2020). A systematic review of trends in all-cause mortality among people with diabetes. Diabetologia. 63(9). 1718–1735. 43 indexed citations
8.
Akhter, Afroza, Thomas R. Hird, Ella Zomer, et al.. (2020). The impact of diabetes on the productivity and economy of Bangladesh. BMJ Global Health. 5(6). e002420–e002420. 25 indexed citations
9.
Chin, Ken Lee, Richard Ofori‐Asenso, Si Si, et al.. (2019). Cost-effectiveness of first-line versus delayed use of combination dapagliflozin and metformin in patients with type 2 diabetes. Scientific Reports. 9(1). 3256–3256. 16 indexed citations
10.
Hird, Thomas R., Ella Zomer, Alice Owen, et al.. (2019). The impact of diabetes on productivity in China. Diabetologia. 62(7). 1195–1203. 40 indexed citations
11.
Hird, Thomas R., Rakibul Islam, Meda E. Pavkov, et al.. (2019). 1593-P: Time Trends in Diabetes Incidence and Obesity Prevalence in Six Countries. Diabetes. 68(Supplement_1). 3 indexed citations
12.
Hird, Thomas R., Ella Zomer, Alice Owen, et al.. (2019). 1594-P: The Impact of Diabetes on Productivity in China. Diabetes. 68(Supplement_1). 2 indexed citations
13.
Hird, Thomas R., Ella Zomer, Alice Owen, et al.. (2019). Productivity Burden of Hypertension in Australia. Hypertension. 73(4). 777–784. 65 indexed citations
14.
Zomer, Ella, Si Si, Thomas R. Hird, et al.. (2018). Cost-effectiveness of low-dose rivaroxaban and aspirin versus aspirin alone in people with peripheral or carotid artery disease: An Australian healthcare perspective. European Journal of Preventive Cardiology. 26(8). 858–868. 16 indexed citations
15.
Hird, Thomas R., et al.. (2016). Study profile: the Durban Diabetes Study (DDS): a platform for chronic disease research. PubMed. 1. e2–e2. 17 indexed citations
16.
Hird, Thomas R., Fraser Pirie, Tonya M. Esterhuizen, et al.. (2016). Burden of Diabetes and First Evidence for the Utility of HbA1c for Diagnosis and Detection of Diabetes in Urban Black South Africans: The Durban Diabetes Study. PLoS ONE. 11(8). e0161966–e0161966. 40 indexed citations
17.
Hird, Thomas R., et al.. (2016). Lessons from Ebola affected communities: Being prepared for future health crises. 4 indexed citations
18.
Hird, Thomas R. & Nicholas C. Grassly. (2012). Systematic Review of Mucosal Immunity Induced by Oral and Inactivated Poliovirus Vaccines against Virus Shedding following Oral Poliovirus Challenge. PLoS Pathogens. 8(4). e1002599–e1002599. 161 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026